{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-004706","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2022-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.318764+00:00","generated_at":"2026-06-27T08:13:06.466880+00:00","sec_items":["1.01","2.03","3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oncotelic extends JH Darbie note maturity to Mar 2023; issues 33M warrants at $0.15","bullets":["Maturity of convertible notes extended from March 31, 2022 to March 31, 2023 with all but one investor agreeing.","Company to issue 33,000,066 Oncotelic warrants at an exercise price of $0.15 per common share.","Each Unit holder receives 333,334 warrants per Unit purchased as consideration for the extension.","Notes were originally issued in July 2020 as part of JH Darbie Financing units."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-004706","json":"https://secwatch.observer/filing/0001493152-22-004706.json","markdown":"https://secwatch.observer/filing/0001493152-22-004706.md","text":"https://secwatch.observer/filing/0001493152-22-004706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/0001493152-22-004706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:13:06.466880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}